Last update 08 May 2025

Trop-2 x Top I x POLR2A

Basic Info

Related Targets
Trop-2Top IPOLR2A

Related

1
Drugs associated with Trop-2 x Top I x POLR2A
KH815
Target
POLR2A x Top I x Trop-2
Mechanism
POLR2A inhibitors [+2]
Active Org.
Kanghong Biotechnology Group Co., Ltd. [+2]
Originator Org.
Chengdu Kanghong Biotechnologies Co., Ltd.Chengdu Kanghong Biotechnologies Co., Ltd.
Active Indication
Advanced Malignant Solid Neoplasm [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Trop-2 x Top I x POLR2A
NCT06885645
/ Not yet recruitingPhase 1
A Phase 1 Study of KH815 for Injection to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity in Patients With Advanced Solid Tumors
100 Clinical Results associated with Trop-2 x Top I x POLR2A
Login to view more data
100 Translational Medicine associated with Trop-2 x Top I x POLR2A
Login to view more data
0 Patents (Medical) associated with Trop-2 x Top I x POLR2A
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free